What is NDC 70771-1742?

70771-1742 is the product NDC for vigabatrin, Vigabatrin 500 mg/10mL powder, for solution, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for vigabatrin?

16 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

vigabatrin NDC 70771-1742 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1742Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1742Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1742-8	7077117420870771174208	50 PACKET in 1 CARTON (70771-1742-8) / 10 mL in 1 PACKET (70771-1742-1)Marketed from Mar 24, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): vigabatrin
Generic name (nonproprietary): vigabatrin
Active ingredients: Vigabatrin — 500 mg/10mL
Dosage form: Powder, For solution
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214671
Marketing start: Mar 24, 2025
Listing expires: Dec 31, 2027
Identifiers: Product ID 70771-1742_2fd46d14-d59a-4335-9f92-9e029defc7b2SPL ID 2fd46d14-d59a-4335-9f92-9e029defc7b2SPL set ID cd5ebc7a-8d5b-46b4-ad9b-e4a25fa3e26cRxCUI 250820UNII GR120KRT6K
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771174208 followed by a unit qualifier and the quantity

Package 70771-1742-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 7, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Vigabatrin is indicated for the treatment of: Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments; vigabatrin is not indicated as a first line agent ( 1.1 ) Infantile Spasms -monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss ( 1.2 ) 1.1 Refractory Complex Partial Seizures (CPS) Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1742

What is NDC 70771-1742?: 70771-1742 is the product NDC for vigabatrin, Vigabatrin 500 mg/10mL powder, for solution, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: vigabatrin.
What is the active ingredient?: Vigabatrin.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for vigabatrin?: 16 other product NDCs are listed under this name. See all vigabatrin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other vigabatrin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
vigabatrin	Vigabatrin 500 mg/1	Tablet, Film coatedOral	Carnegie Pharmaceuticals LLC	80005-167	80005-0167-11
vigabatrin	Vigabatrin 500 mg/10mL	Powder, For solutionOral	Zydus Pharmaceuticals (USA) Inc.	70710-1494	70710-1494-08
Vigabatrin	Vigabatrin 500 mg/1	For solutionOral	Amneal Pharmaceuticals NY LLC	60219-1425	60219-1425-05
Vigabatrin	Vigabatrin 500 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc	0054-0652	00054-0652-25
Vigabatrin	Vigabatrin 50 mg/mL	For solutionOral	Novadoz Pharmaceuticals LLC	72205-093	72205-0093-50
Vigabatrin	Vigabatrin 500 mg/1	TabletOral	Edenbridge Pharmaceuticals LLC.	42799-950	42799-0950-01
Vigabatrin	Vigabatrin 500 mg/1	TabletOral	Aurobindo Pharma Limited	59651-367	59651-0367-01
vigabatrin	Vigabatrin 500 mg/1	Tablet, Film coatedOral	Zydus Pharmaceuticals (USA) Inc.	70710-1287	70710-1287-01
vigabatrin	Vigabatrin 500 mg/1	Tablet, Film coatedOral	Zydus Lifesciences Limited	70771-1654	70771-1654-01
Vigabatrin	Vigabatrin 500 mg/1	Powder, For solutionOral	Aurobindo Pharma Limited	59651-366	59651-0366-50

All 17 vigabatrin NDCs

Other NDCs under ANDA 214671

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214671
Product	Strength	Form · route	Labeler	Product NDC
vigabatrin	Vigabatrin 500 mg/10mL	Powder, For solutionOral	Zydus Pharmaceuticals (USA) Inc.	70710-1494